Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1

E74-like ETS transcription factor 5 (ELF5) is involved in a wide spectrum of biological processes, e.g., mammogenesis and tumor progression. We have identified a list of p300-interacting proteins in human breast cancer cells. Among these, ELF5 was found to interact with p300 via acetylation, and the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:NPJ Precis Oncol
Päätekijät: Li, Xiahui, Li, Shujing, Li, Bowen, Li, Yanan, Aman, Sattout, Xia, Kangkai, Yang, Yuxi, Ahmad, Bashir, Wu, Huijian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979705/
https://ncbi.nlm.nih.gov/pubmed/33742100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-021-00158-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia